Previously published literature has demonstrated that CIP2A silencing in cancer cells derived from different tissues, such as HNSCCs, renal cell carcinomas, and breast cancer can have effects on cancer cell invasion and anchorage-independent growth [25], [29], [30]. The gene discussed is CIP2A; the disease is renal cell carcinoma.